SciTransfer
Organization

REGION SYDDANMARK

Danish regional health authority providing clinical infrastructure, patient registries, and real-world deployment sites for European liver disease, eHealth, and precision medicine research.

Public authorityhealthDK
H2020 projects
14
As coordinator
1
Total EC funding
€6.6M
Unique partners
267
What they do

Their core work

Region of Southern Denmark is a Danish regional public health authority that manages hospitals, healthcare services, and public health initiatives across southern Denmark. In H2020, they contribute real-world clinical data, patient registries, and regional healthcare infrastructure to European research consortia — particularly in liver disease, eHealth implementation, and population health monitoring. They bridge the gap between clinical research and health system deployment, bringing practical experience in how digital health tools and diagnostic protocols are adopted across hospital networks.

Core expertise

What they specialise in

Liver disease research and screeningprimary
4 projects

Central role across GALAXY (alcoholic liver fibrosis), MICROB-PREDICT (cirrhosis biomarkers), LiverScreen (population screening for fibrosis), and SPIOMET4HEALTH (liver fat in PCOS).

eHealth and digital health deploymentprimary
3 projects

Coordinated ImpleMentAll on tailored eHealth implementation strategies, contributed to ADLIFE on personalized care platforms, and participated in Clinnova digital health centre of excellence.

Birth defects and child health registriessecondary
1 project

Contributed hospital discharge data and registry linkage expertise to EUROlinkCAT, tracking outcomes of children with congenital anomalies across Europe.

Microbiome and biomarker scienceemerging
2 projects

Engaged in MICROB-PREDICT on microbiome-based cirrhosis biomarkers and IHMCSA on international microbiome coordination and standards.

1 project

Participated in EURIPHI on European-wide innovative procurement of health innovation, including value-based healthcare and cross-border care models.

Evolution & trajectory

How they've shifted over time

Early focus
Clinical registries and trials
Recent focus
Digital health and precision medicine

In their early H2020 period (2016–2018), the region focused on clinical registries, congenital anomaly surveillance, and traditional clinical trials such as the HIPGEN cell therapy study — working primarily as a data provider and clinical site. From 2019 onward, their focus shifted decisively toward digital health systems, personalized care platforms, microbiome-based diagnostics, and health system innovation including value-based procurement. This evolution reflects a regional health authority transforming from passive data contributor to active driver of how digital tools and predictive models get deployed in real hospital settings.

Moving toward integrating microbiome diagnostics and AI-driven clinical decision support into routine regional healthcare, making them a strong partner for projects needing real-world health system deployment sites.

Collaboration profile

How they like to work

Role: active_partnerReach: European30 countries collaborated

Overwhelmingly a participant (12 of 14 projects), with one coordination role in ImpleMentAll — a major eHealth implementation project. With 267 unique partners across 30 countries, they operate as a well-connected node in large European health consortia rather than leading them. Their value lies in providing clinical infrastructure, patient access, and real-world validation environments, making them a reliable institutional partner rather than a scientific driver.

Extensive European network spanning 267 unique partners across 30 countries, indicating deep integration into the continent's health research ecosystem. Their reach is broad rather than concentrated, reflecting participation in large multi-site clinical and public health consortia.

Why partner with them

What sets them apart

Unlike universities or research institutes, Region Syddanmark brings the operational reality of a regional health system — hospitals, patient registries, procurement authority, and deployment infrastructure. This makes them irreplaceable for projects that need to move beyond lab results into real clinical environments. Their rare combination of liver disease clinical expertise and eHealth implementation experience positions them uniquely for projects targeting digitally-enabled chronic disease management.

Notable projects

Highlights from their portfolio

  • ImpleMentAll
    Their only coordinated project (EUR 1.49M) — led a multi-country effort on tailored eHealth implementation strategies, signaling their strongest institutional commitment.
  • GALAXY
    Largest single funding (EUR 1.19M) in a major liver disease consortium studying gut-liver axis in alcoholic fibrosis, anchoring their liver disease expertise.
  • MICROB-PREDICT
    EUR 887K in an ambitious microbiome-based diagnostic project running until 2026, representing their forward-looking investment in precision hepatology.
Cross-sector capabilities
Digital health and ICT in healthcareEnvironmental health and chemical mixtures (PANORAMIX)Cyber-physical systems safety (SafeCOP)Public health data infrastructure
Analysis note: Strong profile with 14 projects providing clear thematic patterns. Some early projects lack keyword data, but project titles and descriptions allow reliable inference. The liver disease cluster and eHealth coordination role are well-evidenced.